Brown Seaweed Shows No Effect on Blood Glucose in Diabetes
This pilot study investigated the effect of brown seaweed on glucose regulation in patients with type 2 diabetes, finding no significant differences in key outcomes.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This pilot study investigated the effect of brown seaweed on glucose regulation in patients with type 2 diabetes, finding no significant differences in key outcomes.
This study evaluated a new education program for insulin pump users transitioning to a different pump. The program significantly improved time in range and psychosocial self-efficacy compared to usual care.
This study evaluated the impact of real-time continuous glucose monitoring (RT-CGM) on glycemic control in prediabetes. The RT-CGM group showed significant improvements in HbA1c compared to controls.
This study explored the experiences of individuals with Type 2 Diabetes using real-time continuous glucose monitoring (rtCGM) while on insulin. Participants reported significant improvements in glycaemia and overall well-being.
This study investigated the impact of fully closed-loop insulin delivery on self-management in adolescents with type 1 diabetes, finding improvements in quality of life.
This study evaluated the effectiveness of real-time continuous glucose monitoring (rtCGM) compared to self-monitoring of blood glucose (SMBG) in adults with insulin-requiring type 2 diabetes, finding significant improvements in glucose control with rtCGM.
This study evaluated the impact of automated insulin delivery on hypoglycemia risk in adults with Type 1 diabetes, finding significant reductions in time below range.
This study investigated the pharmacokinetics of intranasal naloxone in adults with Type 1 diabetes during exercise, revealing variable plasma concentrations without significant hypoglycemic response correlations.
This randomized pilot trial evaluated the effects of fecal microbiota transplantation (FMT) in patients with type 1 diabetes and gastroenteropathy, finding significant improvements in gastrointestinal symptoms.
This study evaluated the early initiation of Automated Insulin Delivery (AID) in youth with Type 1 Diabetes from underresourced backgrounds. It found that AID showed potential benefits in satisfaction but did not significantly improve time in range compared to usual care.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.